GEHC — GE HealthCare Technologies Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapNeutral

Annual income statement for GE HealthCare Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	17,164	17,585	18,341	19,552	19,672
Cost of Revenue
Gross Profit	6,767	7,174	7,179	7,922	8,205
Selling / General / Administrative Expenses
Research And Development
Total Operating Expenses	14,444	14,790	15,819	17,117	17,047
Operating Profit	2,720	2,795	2,522	2,435	2,625
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	2,710	2,875	2,512	2,361	2,581
Provision for Income Taxes
Net Income After Taxes	2,058	2,275	1,949	1,618	2,050
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	13,846	2,247	1,916	1,568	1,993
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	13,846	2,247	1,916	1,385	1,993
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.19	4.63	4.15	3.5	4.99
Dividends per Share